Tocvan Ventures Corp.

As of May 31, 2026, Tocvan Ventures Corp. carries a market capitalization of 27.64M, placing it among publicly traded companies globally. Its enterprise value stands at 22.51M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Tocvan Ventures Corp.'s next confirmed earnings release is scheduled for December 17, 2026.

As of May 31, 2026, Tocvan Ventures Corp. has 78.74M shares outstanding.

These figures are as of May 31, 2026.

As of May 31, 2026, Tocvan Ventures Corp. maintains a current ratio of 9.16, meaning it holds 9.2x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended May 31, 2026, Tocvan Ventures Corp. posted a negative return on equity (ROE) of -13.18, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -11.83, reflecting losses generated across the asset base.

As of the close on October 22, 2026, Tocvan Ventures Corp.'s stock has declined approximately 38.47% over the past 52 weeks. The 50-day moving average sits at 0.46, while the 200-day moving average is 0.48.

Over the twelve months ended May 31, 2026, Tocvan Ventures Corp. generated - - in revenue and converted that into -1.35M in net income, yielding earnings per share of -0.02. EBITDA reached -1.88M, while operating income came in at -1.88M.

These figures are as of May 31, 2026. Total book value stands at 14.19M, with working capital of 5.13M providing operational flexibility.

Tocvan Ventures Corp. produced -1.62M in operating cash flow over the twelve months ended May 31, 2026.

These figures cover the twelve months ended May 31, 2026. Free cash flow yield is negative at -6.69: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -34.33, meaning Tocvan Ventures Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of May 31, 2026, Tocvan Ventures Corp. has an Altman Z-Score of 25.66, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.